Asset Allocation

As of April 30, 2026.
Type % Net
Cash 2.75%
Stock 10.37%
Bond 87.34%
Convertible 0.00%
Preferred 0.00%
Other -0.46%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 94.32%    % Emerging Markets: 0.13%    % Unidentified Markets: 5.55%

Americas 90.01%
89.50%
Canada 1.27%
United States 88.24%
0.51%
As of April 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 3.87%
United Kingdom 1.37%
2.49%
Austria 0.01%
Denmark 0.04%
Finland 0.01%
France 0.34%
Germany 0.38%
Greece 0.01%
Ireland 0.58%
Italy 0.07%
Netherlands 0.33%
Norway 0.01%
Spain 0.02%
Sweden 0.00%
Switzerland 0.21%
0.00%
0.01%
Greater Asia 0.57%
Japan 0.31%
0.19%
Australia 0.19%
0.07%
Hong Kong 0.00%
Singapore 0.07%
0.00%
Unidentified Region 5.55%

Bond Credit Quality Exposure

AAA 0.03%
AA 34.46%
A 0.00%
BBB 1.67%
BB 22.92%
B 22.51%
Below B 2.61%
    CCC 2.58%
    CC 0.03%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.36%
Not Available 15.44%
Short Term 0.00%
As of April 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical --
Materials --
Consumer Discretionary --
Financials --
Real Estate --
Sensitive --
Communication Services --
Energy --
Industrials --
Information Technology --
Defensive --
Consumer Staples --
Health Care --
Utilities --
Not Classified --
Non Classified Equity --
Not Classified - Non Equity --
No Data Available
View Region Exposure
Start Trial

Bond Sector Exposure

As of April 30, 2026
Type % Net
Government 35.80%
Corporate 61.11%
Securitized 0.56%
Municipal 0.00%
Other 2.53%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.45%
Less than 1 Year
2.45%
Intermediate
95.45%
1 to 3 Years
14.59%
3 to 5 Years
30.95%
5 to 10 Years
49.91%
Long Term
2.02%
10 to 20 Years
1.01%
20 to 30 Years
0.69%
Over 30 Years
0.33%
Other
0.07%
As of April 30, 2026
View Bond Maturity Exposure
Start Trial